Literature DB >> 23565440

Prevalence of polycystic ovary syndrome in young women from North India: A Community-based study.

Harmandeep Gill1, Pallavi Tiwari, Preeti Dabadghao.   

Abstract

BACKGROUND: Polycystic ovary syndrome (PCOS) is one of the most common endocrine disorders in women of reproductive age. Due to the logistics of diagnosis and lack of consensus on the diagnostic criteria, there are very few prevalence studies in the community. This study was aimed to assess the prevalence of PCOS in women 18-25 years of age, conducted in college girls from Lucknow, North India.
MATERIALS AND METHODS: Sample size for the study was calculated as 1052. Girls from 3 different colleges were approached (n = 2150), 1520 (70.7%) agreed to participate. They were asked to fill up a questionnaire asking details of menstrual cycle and features of hyperandrogenism. Hirsutism was self-reported. Responses were verified by a trained research assistant. A probable case was defined as a girl with menstrual irregularity (MI) or hirsutism (H) or both. All the probable cases were invited for detailed examination, hormone estimation, and ovarian ultrasonography.
RESULTS: Of the 1520 girls, 200 (13.1%) were labeled as probable cases; 175 (87.5%) had MI and 25 (12.5%) had both MI and H. Of the 200 cases, 75 (37.5%) had hormonal evaluation while 11 agreed for ultrasonography. 27 girls had confirmed PCOS. Therefore, if all the 200 girls would have had hormonal evaluation, 56 girls were likely to be confirmed as PCOS, giving a calculated prevalence of 3.7% (95% CI, 2.6-4.4) in this population. The mean age of these PCOS cases was 18.96 ± 1.73 yrs, body mass index was 21.72 ± 5.48 Kg/m(2), and waist hip ratio was 0.81 ± 0.08. Only 12% girls had a body mass index ≥ 27.5 Kg/m(2), but 44% had waist hip ratio > 0.81, again highlighting that despite low BMI, Indians have more abdominal obesity.
CONCLUSION: Calculated prevalence of PCOS in women between the ages of 18-25 years from Lucknow, north India, is 3.7%. Majority of these girls were lean but have abdominal obesity.

Entities:  

Keywords:  Body Mass Index (BMI); hirsutism (H); polycystic ovary syndrome (PCOS)

Year:  2012        PMID: 23565440      PMCID: PMC3603088          DOI: 10.4103/2230-8210.104104

Source DB:  PubMed          Journal:  Indian J Endocrinol Metab        ISSN: 2230-9500


INTRODUCTION

Polycystic ovary syndrome (PCOS) is said to be the commonest endocrine disorder of women of reproductive age with a heterogeneous presentation, which includes hyperandrogenism and ovulatory dysfunction. PCOS usually has a peri-pubertal onset; so, it is a disorder of significant health concern. This necessitates estimation of proportion of women are affected by PCOS in the population. The prevalence reported in earlier studies varies between 2.2% to 26%. These variations are due to difficulties in hormonal evaluation and lack of consensus on diagnostic criteria. For diagnosis of PCOS, ovarian ultrasonography and blood tests have to be done in the follicular phase. This limits large epidemiological studies in the community. Using different criteria, prevalence has been estimated as 4.0%–11.9% in the community from 3 different countries. There is paucity of data from India. Insulin resistance is central to the pathogenesis of PCOS, and Indians are known to have high prevalence of insulin resistance, so the prevalence of PCOS may be high in our population. This study was undertaken with the aim to assess prevalence of PCOS in young women (age group 18-25 years) from North India [Figure 1].
Figure 1

Flow Chart

Flow Chart

MATERIALS AND METHODS

Sample size was calculated as 864 with an estimated prevalence of 10%, precision of 2%, and confidence interval of 95%. We added 20% for non-responders making the total number to 1073. We conducted this study in girls’ degree colleges. The girls who volunteered to participate were asked to fill up a questionnaire asking about the details of menstrual history and features of hyperandrogenism. Responses were verified by a trained research assistant. A girl was labeled as a probable case of PCOS if she had menstrual irregularity or hirsutism (self-reported) or both. Menstrual irregularity was defined as the presence of chronic amenorrhea or usual cycle length of >35 days. All probable cases were called for detailed clinical examination to confirm features of hyperandrogenism, anthropometry, hormone estimation, and ovarian ultrasonography. To define biochemical hyperandrogenism, 90 controls from the same population (girls with regular menstrual cycles and no evidence of hyperandrogenism) were studied. Serum testosterone and free androgen index above the 97th percentile were labeled as hyperandrogenism, values of which were 1.76 nmol/L and 5.22 nmol/L, respectively The study was approved by the institutional ethics committee. Written informed consent was obtained from participants prior to detailed evaluation.

RESULTS

About 2150 girls were eligible for the study in the 3 colleges. Of these, 1520 (70.7%) girls volunteered to participate in the study. Out of these 1520 girls, 175 (11.5%) had menstrual irregularity, 27 (1.83%) had hirsutism, and 25 (1.6%) had both menstrual irregularity and hirsutism, making a total of 227 probable cases. All of these 227 cases were invited for further evaluation. 67 (38.3%) of 175 girls with menstrual irregularity, 11 of 25 (44%) with menstrual irregularity and hirsutism group, and just 2 of the only hirsutism group came for further evaluation. There was no difference in the girls who came for further evaluation from those who did not. Out of 80 probable cases, who had hormonal evaluation, 5 girls were excluded because they had secondary causes for menstrual dysfunction. Clinical examination for features of hyperandrogenism showed that the girls tended to over-report hirsutism. So, results are further reported on the 200 girls, 175 with menstrual irregularity and 25 with both. Of the 75 girls with oligo/anovulation, who had further evaluation, 13.3% (10/75) girls had clinically significant hirsutism, 18.9% (14/75) had biochemical hyperandrogenemia. 9.4% (7/75) girls had both clinical as well as biochemical hyperandrogenemia. Only 11 girls agreed for ovarian ultrasonography, and 8 girls were found to have polycystic ovaries. According to the NIH criteria, 21 girls were confirmed to have PCOS. Calculated percentage will be 3.7% (95% CI, 2.6–4.4) [Table 1–5].
Table 1

Distribution of girls according to their presentation, completely evaluated, confirmed, probable, and expected number of case

Table 5

In comparison with other study

Distribution of girls according to their presentation, completely evaluated, confirmed, probable, and expected number of case Demographic characteristics of PCOS cases and controls Univariate logistic regression analysis Multivariate Logistic Regression Analysis In comparison with other study

DISCUSSION

The community prevalence of PCOS in young women (18-25 years) using the NIH criteria in our study was 3.7% (95% CI–2.6–4.4%), which is less than that reported in earlier studies. Using the NIH criteria, a birth cohort study from Australia has shown prevalence of 8.7%. In this study, the definition of menstrual irregularity was very wide, polymenorrhea (<21 days cycle) or a gap between usual cycle lengths of 4-5 days was taken as oligo-anovulation, while in our study, cycle length >35 days was the criteria. Using the Rotterdam criteria where ovarian ultrasonography is a component of diagnosis, in the same cohort, prevalence increased to 11.9%. Contrary to this using the Rotterdam criteria, Kumarapeli et al. have reported a lesser prevalence of 6.1% in Sri Lankan population and 6.3% in Chinese population by Yanmin et al, both are community-based studies Majority of our cases were lean as only 24% had a BMI ≥ 23 Kg/m2, and none was morbidly obese. In contrast, 30-38% subjects are obese in other studies. Obesity can itself cause menstrual irregularity and increase prevalence of PCOS, so this could be a reason for lower prevalence of menstrual irregularity and PCOS in our cohort. In spite of lower prevalence of obesity, waist-hip ratio was abnormal in 44% of PCOS cases, highlighting that Indians have more central obesity, even at low BMI. A significant number of these girls had pre-hypertension; both these factors increasing their long-term cardiovascular disease risk. These abnormal metabolic features are evident, even at the young ages of 18-25 years. The major limitation of our study was that just 40% of the probable cases came for further follow up and evaluation and a minority agreed for ultrasonography.

CONCLUSION

Prevalence of PCOS in young women (18-25 years) was 3.7%, and majority of them were lean. Even at this young age, these women were at a high risk of metabolic syndrome because of the increased prevalence of abnormal waist-hip ratio and pre-hypertension.
Table 2

Demographic characteristics of PCOS cases and controls

Table 3

Univariate logistic regression analysis

Table 4

Multivariate Logistic Regression Analysis

  6 in total

1.  Characteristics of abnormal menstrual cycle and polycystic ovary syndrome in community and hospital populations.

Authors:  Yan-min Ma; Rong Li; Jie Qiao; Xiao-wei Zhang; Shu-yu Wang; Qiu-fang Zhang; Li Li; Bin-bin Tu; Xue Zhang
Journal:  Chin Med J (Engl)       Date:  2010-08       Impact factor: 2.628

2.  A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile.

Authors:  E Diamanti-Kandarakis; C R Kouli; A T Bergiele; F A Filandra; T C Tsianateli; G G Spina; E D Zapanti; M I Bartzis
Journal:  J Clin Endocrinol Metab       Date:  1999-11       Impact factor: 5.958

3.  The prevalence and features of the polycystic ovary syndrome in an unselected population.

Authors:  Ricardo Azziz; Keslie S Woods; Rosario Reyna; Timothy J Key; Eric S Knochenhauer; Bulent O Yildiz
Journal:  J Clin Endocrinol Metab       Date:  2004-06       Impact factor: 5.958

4.  Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study.

Authors:  E S Knochenhauer; T J Key; M Kahsar-Miller; W Waggoner; L R Boots; R Azziz
Journal:  J Clin Endocrinol Metab       Date:  1998-09       Impact factor: 5.958

5.  The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria.

Authors:  Wendy A March; Vivienne M Moore; Kristyn J Willson; David I W Phillips; Robert J Norman; Michael J Davies
Journal:  Hum Reprod       Date:  2009-11-12       Impact factor: 6.918

6.  A simple screening approach for assessing community prevalence and phenotype of polycystic ovary syndrome in a semi-urban population in Sri Lanka.

Authors:  V Kumarapeli; R de A Seneviratne; C N Wijeyaratne; R M S C Yapa; S H Dodampahala
Journal:  Am J Epidemiol       Date:  2008-06-10       Impact factor: 4.897

  6 in total
  11 in total

1.  Impact of yoga and exercises on polycystic ovarian syndrome risk among adolescent schoolgirls in South India.

Authors:  Valarmathi Selvaraj; Jain Vanitha; Fabiola M Dhanaraj; Prema Sekar; Anitha Rajendra Babu
Journal:  Health Sci Rep       Date:  2020-12-04

2.  Evaluation of the Prevalence, Regional Phenotypic Variation, Comorbidities, Risk Factors, and Variations in Response to Different Therapeutic Modalities Among Indian Women: Proposal for the Indian Council of Medical Research-Polycystic Ovary Syndrome (ICMR-PCOS) Study.

Authors:  Mohd Ashraf Ganie; Subhankar Chowdhury; Vanita Suri; Beena Joshi; Prasanta Kumar Bhattacharya; Sarita Agrawal; Neena Malhotra; Rakesh Sahay; Roya Rozati; Puthiyaveettil Khadar Jabbar; Vishnubhatla Sreenivas; Mukesh Sriwastva; Imtiyaz Ahmad Wani; Shalini Singh; Radhey Shyam Sharma
Journal:  JMIR Res Protoc       Date:  2021-08-27

3.  Study on the proportion and determinants of polycystic ovarian syndrome among health sciences students in South India.

Authors:  Nitin Joseph; Aditya G R Reddy; Divya Joy; Vishakha Patel; Pooja Santhosh; Shatarupa Das; Siddharth K Reddy
Journal:  J Nat Sci Biol Med       Date:  2016 Jul-Dec

4.  Body Composition, Metabolic Characteristics, and Insulin Resistance in Obese and Nonobese Women with Polycystic Ovary Syndrome.

Authors:  Anil Satyaraddi; Kripa Elizabeth Cherian; Nitin Kapoor; Aleyamma Thaiparambil Kunjummen; Mohan S Kamath; Nihal Thomas; Thomas V Paul
Journal:  J Hum Reprod Sci       Date:  2019 Apr-Jun

5.  Effect of satapushpa churnam with tila tailam in oligomenorrhea associated with polycystic ovarian syndrome.

Authors:  Jyothi Jacob; N Vijayakumar; Jeby Jose Olickal
Journal:  J Ayurveda Integr Med       Date:  2021-11-02

6.  Prevalence of metabolic syndrome in the family members of women with polycystic ovary syndrome from North India.

Authors:  Iram Shabir; Mohd Ashraf Ganie; Mohd Afzal Zargar; Dilafroz Bhat; Mohd Muzzafar Mir; Aleem Jan; Zaffar Amin Shah; Vicar Jan; Riyaz Rasool; Andleeb Naqati
Journal:  Indian J Endocrinol Metab       Date:  2014-05

7.  Polycystic Ovary Syndrome in Bipolar Affective Disorder: A Hospital-based Study.

Authors:  Sabreena Qadri; Arshad Hussain; Mohammad Hayat Bhat; Aadil Ashraf Baba
Journal:  Indian J Psychol Med       Date:  2018 Mar-Apr

Review 8.  Epidemiology, pathogenesis, genetics & management of polycystic ovary syndrome in India.

Authors:  Mohammad Ashraf Ganie; Vishnu Vasudevan; Imtiyaz Ahmad Wani; Mohammad Salem Baba; Tasleem Arif; Aafia Rashid
Journal:  Indian J Med Res       Date:  2019-10       Impact factor: 2.375

Review 9.  The Prevalence of Polycystic Ovary Syndrome: A Brief Systematic Review.

Authors:  Ritu Deswal; Vinay Narwal; Amita Dang; Chandra S Pundir
Journal:  J Hum Reprod Sci       Date:  2020-12-28

10.  Treatment pathways traversed by polycystic ovary syndrome (PCOS) patients: A mixed-method study.

Authors:  Ishwarpreet Kaur; Vanita Suri; Satya Vati Rana; Amarjeet Singh
Journal:  PLoS One       Date:  2021-08-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.